Escitalopram and Oxytocin drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Escitalopram (escitalopram oxalate) and Oxytocin (oxytocin). Common drug interactions include small for dates baby among females and foetal exposure during pregnancy among males.

The phase IV clinical study analyzes what interactions people have when they take Escitalopram and Oxytocin. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Escitalopram?

Escitalopram has active ingredients of escitalopram oxalate. It is often used in depression. eHealthMe is studying from 78,080 Escitalopram users. Check the latest studies of Escitalopram.

What is Oxytocin?

Oxytocin has active ingredients of oxytocin. It is often used in pain. eHealthMe is studying from 3,083 Oxytocin users. Check the latest studies of Oxytocin.



On Jul, 12, 2026

19 people who take Escitalopram and Oxytocin together, and have interactions are studied.

Escitalopram and Oxytocin drug interactions.

What are the common drug interactions of Escitalopram and Oxytocin, by gender? *:

female:

  1. Small for dates baby (an unborn baby is growing more slowly and is smaller than most babies are at the same age)
  2. Temperature regulation disorder (body is unable to maintain temperature)
  3. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  4. Drug ineffective
  5. Abdominal distension
  6. Abdominal pain upper
  7. Chronic kidney disease
  8. Drug exposure during pregnancy
  9. Foetal movements decreased
  10. Hypertension (high blood pressure)

male:

  1. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  2. Cyanosis (lack of oxygen in body leads to blue appearance of skin ,mucous membrane nails)
  3. Maternal exposure during pregnancy (use of substance during pregnancy)
  4. Neonatal hypoxia (lack of oxygen in neonate)
  5. Overdose
  6. Tachypnoea (a condition of rapid breathing over 20 per minute)
  7. Hypoglycaemia (deficiency of glucose in the bloodstream)
  8. Hypoxia (low oxygen in tissues)
  9. Respiratory depression (respiration has a rate below 12 breaths)
  10. Respiratory distress (difficulty in breathing)

What are the common drug interactions of Escitalopram and Oxytocin, by age (0-1 to 60+)? *:

0-1:

  1. Foetal exposure during pregnancy (exposing your unborn child to contraindicated in pregnancy leads birth defect)
  2. Small for dates baby (an unborn baby is growing more slowly and is smaller than most babies are at the same age)
  3. Temperature regulation disorder (body is unable to maintain temperature)
  4. Overdose
  5. Neonatal respiratory depression (the rate and/or depth of respiration are insufficient to maintain adequate gas exchange in the lungs in neonate)

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Drug ineffective
  2. Chronic kidney disease
  3. Hypertension (high blood pressure)

40-49:

n/a

50-59:

n/a

60+:

n/a

What are the existing conditions these people have? *

  1. Labor Induction: 9 people, 47.37%
  2. Abortion Threatened (abortion with vaginal bleeding): 8 people, 42.11%
  3. Urinary Tract Infection: 8 people, 42.11%
  4. Stress And Anxiety: 7 people, 36.84%
  5. Generalized Anxiety Disorder (excessive, uncontrollable, unexplained and often irrational worry): 7 people, 36.84%
  6. Induced Labor: 6 people, 31.58%
  7. Panic Disorder: 5 people, 26.32%
  8. Fever: 1 person, 5.26%
  9. High Blood Cholesterol: 1 person, 5.26%
  10. Gastric Disorder (disease of stomach): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Escitalopram and Oxytocin?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Escitalopram and Oxytocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Escitalopram:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Oxytocin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Escitalopram and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Oxytocin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on escitalopram oxalate and oxytocin (the active ingredients of Escitalopram and Oxytocin, respectively), and Escitalopram and Oxytocin (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: